Home Contact Center Add this

At a glance

Debiopharm Group™ (Debiopharm) is a Swiss-headquartered global biopharmaceutical group including five companies active in life sciences with a focus on the development of innovative prescription drugs that target unmet medical needs. Oncology is the group’s main area of expertise. In addition, Debiopharm develops drugs for specific indications in the following therapeutic areas: infectious diseases and orphan drugs.

DEB Drug engine 3